This was a letter to the editor and does not constitute evidence which all sophisticated health care systems subscribe to. If the guideline committee is ignoring this retrospective data troll, then it is not our place to try and usurp the committee recommendations.

The comments made that Erbitux not be used outside clinical trials flies in the face of the guidelines suggesting that it is not the opinion of the wider expert group.